Trial Profile
A Single-Center, Randomized, Blinded, Placebo- and Active-Controlled Crossover Study to Evaluate the Effect of Dexpramipexole (BIIB050) on the QTc Interval in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2014
Price :
$35
*
At a glance
- Drugs Dexpramipexole (Primary) ; Moxifloxacin
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Knopp Biosciences
- 24 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2012 New trial record